Heart muscle disease in familial hypokalaemic periodic paralysis

2009 ◽  
Vol 64 (1) ◽  
pp. 12-21 ◽  
Author(s):  
O. J. S. Buruma ◽  
J. J. Schipperheyn ◽  
G. Th. A. M. Bots
2020 ◽  
Vol 2 (2) ◽  
Author(s):  
Tomoya Kubota ◽  
Fenfen Wu ◽  
Savine Vicart ◽  
Maki Nakaza ◽  
Damien Sternberg ◽  
...  

Abstract Familial hypokalaemic periodic paralysis is a rare skeletal muscle disease caused by the dysregulation of sarcolemmal excitability. Hypokalaemic periodic paralysis is characterized by repeated episodes of paralytic attacks with hypokalaemia, and several variants in CACNA1S coding for CaV1.1 and SCN4A coding for NaV1.4 have been established as causative mutations. Most of the mutations are substitutions to a non-charged residue, from the positively charged arginine (R) in transmembrane segment 4 (S4) of a voltage sensor in either CaV1.1 or NaV1.4. Mutant channels have aberrant leak currents called ‘gating pore currents’, and the widely accepted consensus is that this current is the essential pathological mechanism that produces susceptibility to anomalous depolarization and failure of muscle excitability during a paralytic attack. Here, we have identified five hypokalaemic periodic paralysis cases from two different ethnic backgrounds, Japanese and French, with charge-preserving substitutions in S4 from arginine, R, to lysine, K. An R to K substitution has not previously been reported for any other hypokalaemic periodic paralysis families. One case is R219K in NaV1.4, which is located at the first charge in S4 of Domain I. The other four cases all have R897K in CaV1.1, which is located at the first charge in S4 of Domain III. Gating pore currents were not detected in expression studies of CaV1.1-R897K. NaV1.4-R219K mutant channels revealed a distinct, but small, gating pore current. Simulation studies indicated that the small-amplitude gating pore current conducted by NaV1.4-R219K is not likely to be sufficient to be a risk factor for depolarization-induced paralytic attacks. Our rare cases with typical hypokalaemic periodic paralysis phenotypes do not fit the canonical view that the essential defect in hypokalaemic periodic paralysis mutant channels is the gating pore current and raise the possibility that hypokalaemic periodic paralysis pathogenesis might be heterogeneous and diverse.


2021 ◽  
Vol 14 (6) ◽  
pp. e240666
Author(s):  
Alvin Oliver Payus ◽  
Sat Lin Liew ◽  
Nee Tiong ◽  
Norlaila Mustafa

Hypokalaemic periodic paralysis secondary to subclinical hyperthyroidism is an uncommon clinical phenomenon characterised by lower limb paralysis secondary to hypokalaemia in the background of subclinical hyperthyroidism. In this article, we report a patient who presented with progressive lower limb muscle weakness secondary to hypokalaemia that was refractory to potassium replacement therapy. He has no diarrhoea, no reduced appetite and was not taking any medication that can cause potassium wasting. Although he was clinically euthyroid, his thyroid function test revealed subclinical hyperthyroidism. His 24-hour urine potassium level was normal, which makes a rapid transcellular shift of potassium secondary to subclinical hyperthyroidism as the possible cause. He was successfully treated with potassium supplements, non-selective beta-blockers and anti-thyroid medication. This case report aimed to share an uncommon case of hypokalaemic periodic paralysis secondary to subclinical hyperthyroidism, which to our knowledge, only a few has been reported in the literature.


1996 ◽  
Vol 4 (5) ◽  
pp. 175-179 ◽  
Author(s):  
Steven Tracy ◽  
Nora M. Chapman ◽  
José Romero ◽  
Arlene I. Ramsingh

1968 ◽  
Vol 14 (5) ◽  
pp. 1-68 ◽  
Author(s):  
George E. Burch ◽  
Nicholas P. DePasquale
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document